Navigation Links
Baxa Announces 2009 Course Dates for Its STAR Center(R) Training Facility
Date:12/17/2008

Baxa Corporation announces record number of course dates for its STARCenter in 2009. Together with the United States Pharmacopeia (USP), the company plans 22 class sessions focused on pharmacy best practice in relation to USP < 797 > regulatory compliance and hazardous drug handling.

ENGLEWOOD, Colo., Dec. 17 /PRNewswire/ -- Baxa Corporation has published the 2009 course dates for training at its STAR (Skills Training, Academics and Resources) Center. The STAR Center, a premier facility designed for cleanroom and pharmacy practice demonstration, is located at the company's headquarters south of Denver, Colorado. For 2009, Baxa and USP (United States Pharmacopeia) together bring you sixteen opportunities to attend their flagship course, Aseptic Processing and Compliance Tools for USP < 797 >. This two-and-one-half-day seminar will be taught by industry experts and members of the USP < 797 > Sterile Compounding Committee. In addition a companion course, Safe Handling and Preparation of Hazardous Drugs, will be offered six times during the 2009 calendar year with professional faculty.

The first USP compliance class will be held January 28 - 30, 2009, with subsequent program dates running through November, 2009. The ACPE-accredited training is filled on a first-come, first-serve basis and the previous two years' session dates have sold out. Attendance in the STAR Center classes is limited to 20 participants to ensure resource availability, student-teacher ratios and the opportunity for hands-on experience in the cleanrooms.

Baxa, in association with USP, recommends the Aseptic Processing and Compliance Tools for USP < 797 > course to equip compounding professionals with core knowledge and skills toward USP < 797 > compliance. The current programming targets pharmacy and IV managers, as well as pharmacists and technicians with lead responsibility for compounding activities. The program provides value for any personnel compounding sterile preparations or implementing cleanroom principles and practices that comply with USP 797 and industry best practice. Course topics include cleanroom physical design and layout, engineering controls and airflow science, media fill testing and principles associated with workflow, staff training, cleaning, monitoring, validation and documentation.

The Safe Handling and Preparation of Hazardous Drugs course educates pharmacists, technicians, nurses and physicians on how to handle hazardous drugs safely, while complying with regulatory requirements and industry best practice. This ten-hour course covers critical topics including engineering controls required when compounding hazardous drugs, proper use of closed-system drug transfer devices (CSDTDs), procedures for handling hazardous drug spills, hazardous waste containment and disposal and regulatory compliance.

Baxa Corporation sponsors the STAR Center to further best practices in health-system pharmacy operations and facility design. The STAR Center brings together professional and industry partners to provide participants with a range of experiences in equipment, technology and processes. The STAR Center launched in fall 2006. Tuition charged for STAR Center training covers the cost of providing participant meals and training materials, ACPE accreditation and professional speakers' fees. Future class offerings are in development. Contact Baxa Corporation at www.baxa.com/starcenter for more information.

About the STAR Center

The STAR Center is a state-of-the-art cleanroom, pharmacy and training facility located at the Baxa world headquarters in Englewood, Colorado. The center was purpose-built to support training in aseptic technique, pharmacy workflow and practice, cleanroom design and maintenance and USP < 797 > compliance among other topics. Classes are taught by industry-recognized subject matter experts. Further information is available at www.baxa.com/starcenter.

About the United States Pharmacopeia (USP)

USP is a private, non-profit, standards-setting organization that advances public health by helping to ensure the quality and consistency of medicines, food ingredients, and dietary supplements, promoting the safe and proper use of medications, and verifying ingredients in drugs and dietary supplements. Its standards are recognized worldwide. For more information about USP and its public health programs, visit www.usp.org/newscenter.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at www.baxa.com.

    Contact:
    Marian Robinson, Vice President, Marketing
    Baxa Corporation:  800.567.2292 ext. 2157 or 303.617.2157
    Email:  marian.robinson@baxa.com

    Maggie Chamberlin Holben, APR
    Absolutely Public Relations: 303.984.9801 or 303.669.3558
    Email: maggie@absolutelypr.com

    Sandra Kim, Manager, Media Relations USP
    USP: 301-816-8241
    Email: sek@usp.org


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology: